Company / Capital Expenditures
Revvity Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$73.5M
FY2025
5-year range
$73.5M / $86.6M
FY2021-FY2025
Trend
-15.1%
vs FY2024
Sector context
#72 of 151
Health Care
What the data says
At $74M, Revvity's capital expenditures ranks #72 of 151 in the Health Care sector. Capital Expenditures has fluctuated over the past 10 years, ranging from $32M in FY2016 to $93M in FY2018.
Based on SEC 10-K filings.
$74M in FY2025 with a 5-year CAGR of +2.9%.
Declined from $81M to $74M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -5.0%
- 5-Year CAGR
- +2.9%
- 10-Year CAGR
- -
Sector benchmark
#72 of 151 in Health CareTop 48% of 151This company $73.5M Sector average $271.7M
▼
-72.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +2.9%, indicating consistent growth.
- In FY2025, capital expenditures decreased 15.1% year-over-year.
- Ranks #72 out of 151 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2018.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $73.5M | -15.1% |
| FY2024 | $86.6M | +6.5% |
| FY2023 | $81.4M | -5.0% |
| FY2022 | $85.6M | -0.5% |
| FY2021 | $86.0M | +35.2% |
| FY2020 | $63.6M | -16.6% |
| FY2019 | $76.3M | -18.1% |
| FY2018 | $93.3M | +138.6% |
| FY2017 | $39.1M | +23.3% |
| FY2016 | $31.7M | +12.3% |
As of FY2025 · SEC 10-K · Updated Mar 14, 2026